公司資料
Heron Therapeutics 股價、新聞與催化劑
- 股票代碼:
- HRTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.32 USD (-4.96%)
收盤價
最後更新: 2026年8月17日
85.2M USD
市值
股價為何變動
As of Aug 17, 2026, HRTX closed down 4.96% at $0.3200. No new same-company headline was identified in the current news window.
公司概覽
Acute-Care Medicines
Heron Therapeutics commercializes medicines used in surgical pain management and oncology supportive care. Its portfolio is designed for administration in hospitals, ambulatory surgery centers and infusion settings.
ZYNRELEF
ZYNRELEF is an extended-release local anesthetic combining bupivacaine and meloxicam for postoperative pain. Heron is developing a ready-to-use prefilled syringe intended to improve preparation and operating-room efficiency.
Oncology Supportive Care
CINVANTI and APONVIE are injectable antiemetic products used to prevent nausea and vomiting associated with chemotherapy or surgery. These products complement the company's acute-care commercial infrastructure.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。